Joanna Edwards
Family Medicine · Oblong, ILNPI 1063947067
Payments from drug & device makers
Across 111 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$370
- Lilly USA, LLC$175
- Neurocrine Biosciences, Inc.$164
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$129
- AbbVie$128
- Lundbeck LLC$119
- plus $746 from 17 others
What the payments were for
- Food & beverage$1,830100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $370 |
| Lilly USA, LLC | 11 | $175 |
| Neurocrine Biosciences, Inc. | 8 | $164 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $129 |
| AbbVie | 7 | $128 |
| Lundbeck LLC | 6 | $119 |
| Amgen | 6 | $110 |
| Novartis | 5 | $110 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Harmony Biosciences LLC | 4 | $69 |
| Alkermes, Inc. | 3 | $62 |
| Johnson & Johnson | 4 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $29 |
| Boehringer Ingelheim | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Exact Sciences | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Indivior Inc. | 1 | $15 |
How this compares
$1,830 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 99 | $116,113 |
| EliquisApixaban | 128 | $94,959 |
| JardianceEmpagliflozin | 92 | $84,658 |
| OzempicSemaglutide | 54 | $47,718 |
| XareltoRivaroxaban | 56 | $36,889 |
| Repatha SureclickEvolocumab | 58 | $32,337 |
| TrulicityDulaglutide | 20 | $18,697 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $17,340 |
| JanuviaSitagliptin Phosphate | 20 | $12,966 |
| Praluent PenAlirocumab | 22 | $11,547 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $11,422 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 23 | $11,269 |
| MyrbetriqMirabegron | 22 | $9,920 |
| TradjentaLinagliptin | 15 | $9,566 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $8,461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $175 | $134,810119 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta | $21 | $105,493130 claims |
| Novo NordiskOzempic | $17 | $47,71854 claims |
| Johnson & JohnsonXarelto | $61 | $36,88956 claims |
| Indivior Inc.Suboxone | $15 | $17,34014 claims |
| AbbVieLinzess, Synthroid | $128 | $9,23240 claims |
| AstraZenecaSymbicort | $17 | $4,89623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Oblong
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.